The need for axillary lymph node dissection in T1/T2 breast cancer surgery--reply to counterpoint.
نویسنده
چکیده
7189 OX40 Is a Potent Immune-Stimulating Target in Late-Stage Cancer Patients Brendan D. Curti, Magdalena Kovacsovics-Bankowski, Nicholas Morris, Edwin Walker, Lana Chisholm, Kevin Floyd, Joshua Walker, Iliana Gonzalez, Tanisha Meeuwsen, Bernard A. Fox, Tarsem Moudgil, William Miller, Daniel Haley, Todd Coffey, Brenda Fisher, Laurie Delanty-Miller, Nicole Rymarchyk, Tracy Kelly, Todd Crocenzi, Eric Bernstein, Rachel Sanborn, Walter J. Urba, and Andrew D. Weinberg
منابع مشابه
Standardization of whole breast radiotherapy is required for safe omission of axillary lymph node dissection in breast cancer patients
Background: The purpose of this study was to assess the dose distribution and coverage of level Ⅰ-Ⅱ axillary lymph nodes during whole breast tangential field radiotherapy (RT) after breast-conserving surgery in patients with breast cancer. Materials and Methods: The level Ⅰ-Ⅱ axillary lymph node volumes were retrospectively contoured by a single radiation oncologist based on computed tomography...
متن کاملDissection axillary lymph node count in patient with breast cancer followed by neoadjuvant therapy
Introduction: Breast cancer is the most common cancer and the second cause of death in women. It is essential to have the highest level of confidence in axillary staging assessment. Many surgeons and pathologists believe that fewer lymph nodes are present in axillary dissection specimens of women treated by neoadjuvant chemotherapy. Consequently, the purpose of this study was to compare the lym...
متن کاملIt is not always necessary to do axillary dissection for T1 and T2 breast cancer--reply to point.
Axillary lymph node dissection (ALND) has been a part of breast cancer management since the 1900s. The idea that axillary metastases do not require surgical removal is a repudiation of the Halstedian concept of breast cancer biology, yet multiple prospective randomized studies show that the incidence of nodal recurrence in patients not having ALND is substantially lower than expected, based on ...
متن کاملبررسی رابطه بین شاخص توموری 2-Her و قدرت تهاجمی سرطان پستان(متاستاز به غدد لنفاوی زیر بغل) در بیماران ماستکتومی شده در انستیتو کانسر طی سال‌های 82-1380
Breast cancer is the most common site-specific cancer and is the second cause of mortality due to cancer in women. There are different prognostic factors including: axillary nodal status and tumor size(the most important factor), ER activity, PR, tumor grade and the type of histology. Other incompletely defined risk factors are: protease, catepstin, Her-2, etc. Her-2 is subtype 2 of E...
متن کاملPrediction Axillary Lymph Node Involvement Status on Breast Cancer Data
Introduction: one of the foremost usual methods for evaluating breast cancer is the removal of axillary lymph nodes (ALN) which include complications such as edema, limited hand movements, and lymph accumulation. Although studies have shown that the sentinel gland condition represents the axillary nodules context in the mammary gland, the efficacy, and safety of the guard node biopsy need to be...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Cancer research
دوره 73 24 شماره
صفحات -
تاریخ انتشار 2013